NASDAQ: SNWVSanuwave Health Inc Stock
$29.98+0.75 (+2.57%)
Updated Apr 17, 2025
SNWV Price
$29.98
Fair Value Price
N/A
Market Cap
$256.28M
52 Week Low
$26.00
52 Week High
$39.50
P/E
-4.26x
P/B
-20.15x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$32.63M
Earnings
-$31.37M
Gross Margin
75.2%
Operating Margin
-54.26%
Profit Margin
-96.1%
Debt to Equity
-3.37
Operating Cash Flow
$2M
Beta
0.55
Next Earnings
May 8, 2025
Ex-Dividend
N/A
Next Dividend
N/A
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine SNWV's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
D
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Device
Industry Rating
C
SNWV
Ranked#32 of 102
Ranked#32 of 102
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $7.82 | A | |
| $22.79 | A | |
| $13.33 | A |
Be the first to know about important SNWV news, forecast changes, insider trades & much more!
SNWV News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how SNWV scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SNWV is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SNWV is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
SNWV's Earnings (EBIT) of -$17.71M... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more SNWV due diligence checks available for Premium users.
Valuation
SNWV fair value
Fair Value of SNWV stock based on Discounted Cash Flow (DCF)
Price
$29.98
Fair Value
-$7.72
Undervalued by
488.57%
SNWV is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
SNWV price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-4.26x
Industry
41.14x
Market
27.98x
SNWV price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-20.15x
Industry
3.8x
SNWV's financial health
Profit margin
Revenue
$10.3M
Net Income
-$12.7M
Profit Margin
-123.5%
SNWV's Earnings (EBIT) of -$17.71M... subscribe to Premium to read more.
Interest Coverage Financials
SNWV's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$30.1M
Liabilities
$42.8M
Debt to equity
-3.37
SNWV's short-term liabilities ($42.35M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SNWV's short-term assets ($18.40M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SNWV's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SNWV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$741.0k
Investing
-$236.0k
Financing
$6.5M
SNWV's operating cash flow ($2.46M)... subscribe to Premium to read more.
Debt Coverage Financials
SNWV vs Medical Device Stocks
Sanuwave Health Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.